A new preclinical study from Weill Cornell Medicine found that the protein caspase-5 (CASP5), long thought to be a foot ...

Ampersand Biomedicines, a Flagship Pioneering multi-product platform company developing smarter medicines that act specifically at the site of disease and nowhere else, today announced new preclinical ...

Ampersand Biomedicines presents preclinical data on AMP-220, a gut-targeted IL-22 AND-Body therapeutic, at AAI 2026: Boston Tuesday, April 21, 2026, 17:00 Hrs [IST] Ampersand Biom ...

Scientists have uncovered a novel mechanism through which skin cells organize and control protein production during ...

Researchers have identified a molecular mechanism that helps prevent common skin cancers from becoming aggressive and metastatic. The study, published in Proceedings of the National Academy of ...

Vector-10 is a registered trademark and patented technology of Vera Clinic. All clinical data collected under institutional ...

AstraZeneca’s chronic obstructive pulmonary disease (COPD) candidate has served up a third phase 3 win this year, offering ...

Pharmacologic data highlight durable GI microbiome modulation, with improvement in epithelial barrier integrity, following SER-155 ...

A new study has identified a molecular guardian that keeps skin cells from forgetting what they are and transforming into ...

There’s more history in your blood types than you think, and it didn’t begin with humans. Here’s what we know about them, ...

Stress fiber–generated traction forces critically regulate mesenchymal stem cell (MSC) behavior, yet how mechanical cues are ...

A 76-year-old man on cancer immunotherapy developed a mixed Mycobacterium tuberculosis and Aspergillus fumigatus empyema with pneumothorax, exposing key diagnostic and therapeutic gaps.